Frontier Group Holdings, Inc. ULCC NASDAQ · Industrials · United States
$8.17 +5.63% +$0.44
Summary
23 / 100 · Bulios Score
What speaks for it
- Analysts expect revenue to grow by 33% this fiscal year.
What to watch
- The company made a loss over the last 12 months.
- The share price is above the Bulios Fair Price.
- Revenue growth is slowing: 3.8% a year over the last 3 years against 24% over 5 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBy our assumptions the business is worth less than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 24% a year over 5 years. Over the last 3 years it grew by 3.8% a year. For the next fiscal year analysts expect revenue to grow by 33%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $413.0M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 60.8 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 2
- Hold 8
- Sell 3
Today's price within the analysts' price targets
The average target of $6 is 27% below today's price. 15% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Passenger 38%
- Non-Fare Passenger Revenue 22%
- Aircraft Fare 16%
- Passenger Service Fees 10%
- Passenger Baggage 7.9%
- Other 5.8%
By region
- Latin America Destination 100%
Passenger brings in 38% of revenue. Aircraft Fare grew fastest, by 16% a year.
Segments in detail